Skip to content
Home/Companies/Biotech/Sophia Genetics
SG

Sophia Genetics

Biotech·Switzerland·Active·7yr hold

Sophia Genetics is a TMT company, headquartered in Switzerland.

Entry
2019
Hold
7yr
Status
Active
Est. EV

Who owns Sophia Genetics?

Sophia Genetics is currently owned by Eurazeo through Eurazeo Growth Fund III (2019 vintage), since 2019. Across its history, Sophia Genetics has been through 4 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Eurazeo
Most recent investor
Eurazeo
Eurazeo Growth Fund III · 2019 · Growth
4 ownership periods · full history below

Key facts

HQSwitzerland
SectorTMT
Key takeaways
  • ·Held by Eurazeo since 2019 (7Y hold).
  • ·Average hold across 3 realized cycles: 3 years.
  • ·4 distinct PE sponsors across ownership cycles.

Ownership history

4 ownership periods · co-invest detected

Active
Currently held by Eurazeo since 2019.
Co-invest · 4 holders · 2014 · present
360 Capital Partners
2014 · 2021 · 360 Capital 2011 · 2011 · VC
IPO
MOIC
Balderton Capital
2019 · 2021 · Balderton Capital VII · 2019 · VC
IPO
MOIC
Eurazeo
EurazeoActive
2019 · present · Eurazeo Growth Fund III · 2019 · Growth
MOIC
Hitachi Ventures
Hitachi VenturesExited 2021
2020 · 2021 · Hitachi Ventures Fund I · 2019 · VC
MOIC
Data refreshed weekly · Sourced from public filings